Nucor (NUE) Competitors

76.5% of Nucor shares are held by institutional investors. 1.0% of ATI shares are held by company insiders. Comparatively, 0.6% of Nucor shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Nucor had 28 more articles in the media than ATI. MarketBeat recorded 35 mentions for Nucor and 7 mentions for ATI. Nucor's average media sentiment score of 1.15 beat ATI's score of 0.84 indicating that Nucor is being referred to more favorably in the news media.

Nucor has higher revenue and earnings than ATI. Nucor is trading at a lower price-to-earnings ratio than ATI, indicating that it is currently the more affordable of the two stocks.

ATI currently has a consensus target price of $164.38, suggesting a potential downside of 19.41%. Nucor has a consensus target price of $266.33, suggesting a potential upside of 8.84%. Given Nucor's higher probable upside, analysts plainly believe Nucor is more favorable than ATI.

ATI has a beta of 0.96, suggesting that its share price is 4% less volatile than the broader market. Comparatively, Nucor has a beta of 1.88, suggesting that its share price is 88% more volatile than the broader market.

ATI has a net margin of 9.26% compared to Nucor's net margin of 6.82%. ATI's return on equity of 26.44% beat Nucor's return on equity.

Cabot has a net margin of 7.97% compared to Nucor's net margin of 6.82%. Cabot's return on equity of 21.33% beat Nucor's return on equity.

In the previous week, Nucor had 32 more articles in the media than Cabot. MarketBeat recorded 35 mentions for Nucor and 3 mentions for Cabot. Nucor's average media sentiment score of 1.15 beat Cabot's score of 0.00 indicating that Nucor is being referred to more favorably in the news media.

Nucor has higher revenue and earnings than Cabot. Cabot is trading at a lower price-to-earnings ratio than Nucor, indicating that it is currently the more affordable of the two stocks.

Cabot presently has a consensus price target of $83.80, suggesting a potential downside of 7.72%. Nucor has a consensus price target of $266.33, suggesting a potential upside of 8.84%. Given Nucor's stronger consensus rating and higher possible upside, analysts clearly believe Nucor is more favorable than Cabot.

93.2% of Cabot shares are held by institutional investors. Comparatively, 76.5% of Nucor shares are held by institutional investors. 3.1% of Cabot shares are held by insiders. Comparatively, 0.6% of Nucor shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Cabot has a beta of 0.82, suggesting that its share price is 18% less volatile than the broader market. Comparatively, Nucor has a beta of 1.88, suggesting that its share price is 88% more volatile than the broader market.

Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.1%. Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 0.9%. Cabot pays out 35.7% of its earnings in the form of a dividend. Nucor pays out 22.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cabot has increased its dividend for 14 consecutive years and Nucor has increased its dividend for 52 consecutive years.

76.5% of Nucor shares are held by institutional investors. Comparatively, 76.3% of Chemours shares are held by institutional investors. 0.6% of Nucor shares are held by company insiders. Comparatively, 0.9% of Chemours shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Nucor has a beta of 1.88, meaning that its share price is 88% more volatile than the broader market. Comparatively, Chemours has a beta of 1.4, meaning that its share price is 40% more volatile than the broader market.

Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 0.9%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 1.6%. Nucor pays out 22.2% of its earnings in the form of a dividend. Chemours pays out -13.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nucor has increased its dividend for 52 consecutive years. Chemours is clearly the better dividend stock, given its higher yield and lower payout ratio.

Nucor has a net margin of 6.82% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat Nucor's return on equity.

Nucor presently has a consensus price target of $266.33, indicating a potential upside of 8.84%. Chemours has a consensus price target of $24.60, indicating a potential upside of 14.59%. Given Chemours' higher possible upside, analysts plainly believe Chemours is more favorable than Nucor.

In the previous week, Nucor had 33 more articles in the media than Chemours. MarketBeat recorded 35 mentions for Nucor and 2 mentions for Chemours. Nucor's average media sentiment score of 1.15 beat Chemours' score of 0.00 indicating that Nucor is being referred to more favorably in the media.

Nucor has higher revenue and earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Nucor, indicating that it is currently the more affordable of the two stocks.

Celanese currently has a consensus price target of $67.81, indicating a potential upside of 36.36%. Nucor has a consensus price target of $266.33, indicating a potential upside of 8.84%. Given Celanese's higher probable upside, analysts plainly believe Celanese is more favorable than Nucor.

Celanese pays an annual dividend of $0.12 per share and has a dividend yield of 0.2%. Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 0.9%. Celanese pays out -1.2% of its earnings in the form of a dividend. Nucor pays out 22.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nucor has increased its dividend for 52 consecutive years. Nucor is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Celanese has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market. Comparatively, Nucor has a beta of 1.88, suggesting that its stock price is 88% more volatile than the broader market.

98.9% of Celanese shares are owned by institutional investors. Comparatively, 76.5% of Nucor shares are owned by institutional investors. 0.3% of Celanese shares are owned by company insiders. Comparatively, 0.6% of Nucor shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Nucor has a net margin of 6.82% compared to Celanese's net margin of -11.54%. Nucor's return on equity of 10.68% beat Celanese's return on equity.

In the previous week, Nucor had 28 more articles in the media than Celanese. MarketBeat recorded 35 mentions for Nucor and 7 mentions for Celanese. Nucor's average media sentiment score of 1.15 beat Celanese's score of 0.26 indicating that Nucor is being referred to more favorably in the news media.

Nucor has higher revenue and earnings than Celanese. Celanese is trading at a lower price-to-earnings ratio than Nucor, indicating that it is currently the more affordable of the two stocks.